Zhenhuan Liu professor of pediatrics,Pediatric acupuncturist Ph.D.tutor. He has been engaged in pediatric clinical and child rehabilitation for 40 years. Led the rehabilitation team to treat more than 40,000 cases of children with intellectual disability, cerebral palsy and autism from China and more than 20 countries,More than 26800 childrens deformity returned to school and society and became self-sufficient. The rehabilitation effect ranks the international advanced level.Vice-chairman of Rehabilitation professional committe children with cerebral palsy,World Federation of Chinese Medicine Societies. Visiting Profassor of Chinese University of Hong Kong in recent 10 years. .He is most famous pediatric neurological and rehabilitation specialists in integrated traditional Chinese and Western medicine in China. He has edited 10 books.He has published 268 papers in international and Chinese medical journals.
Italo Mocchetti
Italo Mocchetti
USA
Dr. Mocchetti is a Professor of Neuroscience at Georgetown University Medical Center, Washington, DC. The primary focus of Dr. Mocchetti’s research program at Georgetown University is to develop new biotherapies for human neurological disorders, such as Alzheimer’s and Parkinson’s diseases, and neurocognitive disorders caused by human immunodeficiency virus (HIV). Currently, Dr. Mocchetti’s group is using animal models to characterize the molecular and cellular mechanisms utilized by HIV to promote neuronal degeneration. His research has been funded for 20 years from NINDS.
Herbert B. Newton
University Hospitals Cleveland
USA
Dr. Newton is the Medical Director of the Neuro-Oncology Program & Brain Tumor Institute, and Professor of Neurology & Solid Tumor Oncology at the University Hospitals of Cleveland Medical Center and Seidman Cancer Center, Case Western Reserve University School of Medicine. He holds the UH Neurological Institute Chair in Memory and Cognition, and has been practicing academic Neuro-Oncology for > 30 years. He has published more than 230 articles and book chapters, along with being the Editor or Co-Editor of 13 books, in the fields of Neurology and Neuro-Oncology.
Graziano Pinna
University of Illinois Chicago
USA
Pinna’s preclinical and clinical research focuses on stress-induced neuropsychiatric disorders, with a special emphasis on conditions impacting women’s mental health, including PMS, PMDD, post-partum depression (PPD), PTSD, and depression. Using a translational approach, he studies the neurobiological basis of emotional dysfunction in animal models and humans, particularly the impact of stress on GABAergic neurosteroid biosynthesis and its interaction with the endocannabinoid system. His work on allopregnanolone contributed to the development of brexanolone (Zulresso™) and zuranolone (Zurzuvae™) for PPD. He also helped develop biomarker assessments for ganaxolone (Ztalmy®) trials. He has published 135 papers and holds 12 active grants.
